Donation

Registration for the Denver Community Workshop is now closed.
Visit our events page to see upcoming workshops and webinars.

 

The International Myeloma Foundation (IMF) is excited to announce that an in-person Regional Community Workshop will take place on June 21, 2025, in Denver, CO.

 

Date and Location:

 

June 21, 2025

Renaissance Denver Hotel & Convention Center
3801 Quebec Street,
Denver, CO 80207

 

 

 

Designed for those seeking support and more information in smaller communities, IMF Regional Community Workshops offer families a condensed version of the full Patient and Family Seminar at no charge. 

The workshop will include an introduction to myeloma, upfront treatments at diagnosis, maintenance therapy, relapse information, and an update on clinical trials. A member of the IMF Nurse Leadership Board will talk about managing side effects and symptoms of myeloma and its treatments. After each presentation with the experts, attendees will have ample time to ask questions.

Connect with local myeloma specialists and experts who will address needs specific to communities in Denver, CO.

Local Expert Speakers:
Sylvia Dsouza
Sylvia Dsouza
IMF VP Development
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO
Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
Peter Forsberg Headshot
Peter Forsberg, MD
Colorado Blood Cancer Institute, Denver, CO
Martha Lacy, MD
Mayo Clinic, Rochester, MN
Daniel Sherbenou, MD, PhD
University of Colorado Hospital Aurora, CO
Robin Tuohy, VP of Patient Support
Robin Tuohy
IMF Vice President, Patient Support
Michael Tuohy
Michael Tuohy
IMF Support Group Leader, 25-Year Myeloma Patient
Mark Cerda, PE
Myeloma Care Partner
Pat Sullivan
Myeloma Patient
Topics Covered in This Workshop:

Welcome and Announcements

Robin Tuohy, IMF Vice President, Patient Support 

Understanding Myeloma Basics

Daniel Sherbenou, MD, PhD
(University of Colorado Hospital Aurora, CO)

Video: Closing the Gap: Health Disparities in Myeloma

Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO
IMF Chief Medical Officer
(TGen, City of Hope—Phoenix, AZ) 

Advancing Treatment Options Through Clinical Trials 

Peter Forsberg, MD
(Colorado Blood Cancer Institute, Denver, CO )

Break-out Options:

  • Newly Diagnosed: Getting Started with Myeloma Management
    Daniel Sherbenou, MD, PhD
    (University of Colorado Hospital Aurora, CO)

  • Relapsed & Refractory: Continuing the Myeloma Treatment Journey
    Peter Forsberg, MD
    (Colorado Blood Cancer Institute, Denver, CO )

Development Update: Partnering with the IMF

Sylvia Dsouza
VP Development, International Myeloma Foundation

Seasons of Myeloma: Managing Side Effects & Living Well

Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO
MF Nurse Leadership Board Member
(Cleveland Clinic Taussig Cancer Institute, Cleveland , OH)

Living the Myeloma Life: Local Patient & Care Partner

  • Patient: Pat Sullivan
  • Care Partner: Mark Cerda, PE

Beyond Myeloma Therapy: Exploring Financial and Legal Issues in Cancer Care

Martha Lacy, MD
(Mayo Clinic, Rochester, MN )

 

8:00 – 9:00 AM Registration
9:00 – 11:45 AM  Morning Session
11:45 – 12:40 PM Lunch
12:40 – 3:30 PM  Afternoon Session
3:30 – 4:00 PM Coffee / Network

 

Additional Resources:
Previous Post
Living Well with Myeloma: Clinical Trials
Next Post
Q&A: Ask Me Anything About Myeloma with Dr. Saad Usmani

Give Where Most Needed